Patents by Inventor Cristobal Guillermo Dos Remedios

Cristobal Guillermo Dos Remedios has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7560226
    Abstract: A method can identify a type of leukemia in a human subject. A biological sample from the human subject that contains CD antigens is obtained. The sample is contacted with an array of immunoglobulin molecules. Each immunoglobulin in the array, with the exception of one or more negative controls, is capable of interaction with a CD antigen on one or more types of leukemia cells. The pattern of interaction between the immunoglobulin molecules and the CD antigens in said sample is then determined, thereby providing an immunophenotype of the cells which is characteristic of the type of leukemia.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: July 14, 2009
    Assignee: Medsaic Pty Limited
    Inventors: Richard Ian Christopherson, Cristobal Guillermo Dos Remedios
  • Publication number: 20020018997
    Abstract: The present invention relates generally to an assay for the detection of toxicants. More particularly, the present invention contemplates an assay of toxicants such as those of the type comprising heavy metal, heavy metal divalent cations and organic molecules as well as organo-halides. Such toxicants are frequently present as contaminants in aquatic and terrestrial environments. The present invention further provides an assay device for detecting toxicants. The present invention is predicated in part on the sensitivity of binding partner affinity to the toxicants.
    Type: Application
    Filed: February 7, 2001
    Publication date: February 14, 2002
    Inventors: Cristobal Guillermo dos Remedios, Murat Kekic, Arthur Roger Cooke
  • Publication number: 20020019018
    Abstract: A method can identify a type of leukemia in a human subject. A biological sample from the human subject that contains CD antigens is obtained. The sample is contacted with an array of immunoglobulin molecules. Each immunoglobulin in the array, with the exception of one or more negative controls, is capable of interaction with a CD antigen on one or more types of leukemia cells. The pattern of interaction between the immunoglobulin molecules and the CD antigens in said sample is then determined, thereby providing an immunophenotype of the cells which is characteristic of the type of leukemia.
    Type: Application
    Filed: June 25, 2001
    Publication date: February 14, 2002
    Inventors: Richard Ian Christopherson, Cristobal Guillermo Dos Remedios